Search results
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 3 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
AOL· 3 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma patients that had received the cancer vaccine combination showed an overall survival rate ...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 6 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine,...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 1 day agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 6 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
5 Stocks Propelling S&P 500 to 25th Record High
Zacks via Yahoo Finance· 2 hours agoThe S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO,...
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 3 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
